VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $69,812,000 | -56.5% | 391,367 | -45.8% | 3.18% | -45.4% |
| Q2 2015 | $160,407,000 | +13.0% | 722,067 | +1.0% | 5.81% | +15.7% |
| Q1 2015 | $141,929,000 | +81.7% | 714,578 | +30.9% | 5.02% | +74.4% |
| Q4 2014 | $78,109,000 | -45.8% | 545,800 | -50.4% | 2.88% | -48.8% |
| Q3 2014 | $144,241,000 | +2.3% | 1,099,400 | -1.6% | 5.63% | +22.9% |
| Q2 2014 | $140,977,000 | – | 1,117,800 | – | 4.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |